levodopa

Names & Synonyms

• levodopa
• L-dopa
• Dopar
• Larodopa
• Bendopa
• 3-Hydroxy-L-tyrosine
• Levopa
• Dopa
• Insulamina
• Brocadopa
• Dopaidan
• Dopalina
• Dopasol
• Eldopal
• Pardopa
• 3,4-dihydroxy-L-phenylalanine
• Cidandopa
• Maipedopa
• Dopaflex
• Deadopa
• Eldopar
• Prodopa
• Syndopa
• Veldopa
• Doparkine
• Dopastral
• Dopaston
• Doparl
• Doprin
• Helfo-Dopa
• 59-92-7
• Eldopatec
• Eurodopa
• Dopal-fher
• Ledopa
• Dopal
• Levodopum
• Levedopa
• Biodopa
• Sobiodopa
• (-)-Dopa
• Laradopa
• Cerepap
• Sinemet
• Parda
• L-o-Hydroxytyrosine
• Dopaston SE
• Dihydroxy-L-phenylalanine
• 3,4-Dihydroxyphenylalanine
• Cerepar
• Inbrija
• Parcopa
• Weldopa
• 3-(3,4-Dihydroxyphenyl)-L-alanine
• Helfo DOPA
• madopar
• dihydroxyphenylalanine
• Stalevo
• Atamet
• Madopa
• L-3,4-Dihydroxyphenylalanine
• L-Tyrosine, 3-hydroxy-
• L Dopa
• Dopastone
• Dopicar
• Leodopa
• Prolopa
• L-Dihydroxyphenylalanine
• 3-Hydroxytyrosine
• levodopa-
• Brocadopa;
• L-(-)-Dopa
• L-3-Hydroxytyrosine
• Mixture Name
• Larodopa;
• Bendopa;
• L-dopa;Levodopa
• IV Levodopa
• Levodopa RS
• Levopa;
• L-Dopa Phenolic
• Levodopa CRS
• 3,4-Dihydroxyphenyl-L-alanine
• Sinemet CR
• Dopar;
• component of Sinemet
• L-(o-Dihydroxyphenyl)alanine
• D-Dopa
• Dopar (TN)
• (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
• L-O-Dihydroxyphenylalanine
• Levodopum [INN-Latin]
• 3 Hydroxy L tyrosine
• L(-)-Dopa
• Prestwick_185
• Levodopa (Sinemet)
• Tyrosine, 3-hydroxy-
• L-DOPA; Levodopa
• Madopa (Salt/Mix)
• (-)-3-(3,4-Dihydroxyphenyl)-L-alanine
• Levodopa, food grade
• Sinemet (Salt/Mix)
• C9H11NO4
• beta-(3,4-Dihydroxyphenyl)-L-alanine
• L-DOPA (Standard)
• RefChem:6454
• L-beta-(3,4-Dihydroxyphenyl)alanine
• Spectrum_000454
• 4-dihydroxyphenylalanine
• CVT-301
• L-3-(3,4-Dihydroxyphenyl)alanine
• LEVODOPA [HSDB]
• LEVODOPA [USAN]
• LEVODOPA [INN]
• LEVODOPA [JAN]
• beta-(3,4-Dihydroxyphenyl)alanine
• Carbidopa EP Impurity A
• LEVODOPA [MI]
• MFCD00002598
• Ro 4-6316
• AC1L1LOR
• L-3,4-Dihydrophenylalanine
• LEVODOPA [VANDF]
• Prestwick0_000017
• Prestwick1_000017
• Prestwick2_000017
• Prestwick3_000017
• Spectrum2_000496
• Spectrum4_000539
• Spectrum5_001899
• CCRIS 3766
• CHEMBL1009
• L-Tirosina, 3-hidroxi-
• Lopac-D-9628
• Levodopa (JP15/USP)
• LEVODOPA [MART.]
• DTXSID9023209
• L 3,4 Dihydroxyphenylalanine
• bmse000322
• CHEBI:15765
• D08HVR
• Epitope ID:150927
• L DOPA 4X
• LEVODOPA [USP-RS]
• LEVODOPA [WHO-DD]
• LEVODOPA [WHO-IP]
• HSDB 3348
• AC1Q4U7F
• DOPA, L-
• L-Dopa 1514
• 3,4-Dihydroxy-L-Phe-OH
• DHIVY COMPONENT LEVODOPA
• DTXCID303209
• DUOPA COMPONENT LEVODOPA
• WLN: QVYZ1R CQ DQ
• WTDRDQBEARUVNC-LURJTMIESA-N
• 3, 4-Dihydroxyphenylalanine
• Alanine,4-dihydroxyphenyl)-
• LEVODOPA [EMA EPAR]
• (-)-3-Hydroxy-L-tyrosine
• 3,4-Dihydroxyphenylalanine (VAN)
• alanine, 3-(3,4-dihydroxyphenyl)-, L-
• Lopac0_000454
• RYTARY COMPONENT LEVODOPA
• SCHEMBL22655
• BSPBio_000053
• BSPBio_002354
• CARBIDOPA AND LEVODOPA
• KBioGR_001177
• KBioSS_000934
• Levodopa (1361009)
• CREXONT COMPONENT LEVODOPA
• L-(3,4-Dihydroxyphenyl)alanine
• L-4-5-Dihydroxyphenylalanine
• L-DOPA-2,5,6-d3
• MLS000028514
• STALEVO COMPONENT LEVODOPA
• (-)-(3,4-Dihydroxyphenyl)alanine
• BIDD:GT0158
• DivK1c_000452
• L-Dopa, L-3-Hydroxytyrosine
• NSC-118381
• SPECTRUM2300205
• EINECS 200-445-2
• Levodopa (JP18/USP/INN)
• Levodopa [USAN:INN:BAN:JAN]
• SPBio_000391
• SPBio_001974
• CORBILTA COMPONENT LEVODOPA
• LEVODOPA [EP IMPURITY]
• LEVODOPA [ORANGE BOOK]
• NSC118381
• BPBio1_000059
• GTPL3639
• orb1310238
• Phenylalanine, 3,4-dihydroxy-
• SCHEMBL3857245
• UNII-46627O600J
• (S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
• LEVODOPA [EP MONOGRAPH]
• (S)-3,4-dihydroxyphenylalanine
• b-(3,4-Dihydroxyphenyl)alanine
• beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine
• L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine
• LEVODOPA [USP MONOGRAPH]
• NSC 118381
• SCHEMBL29373537
• WLN: QVYZ1R CQ DQ -L
• 3, 4-Dihydroxy-L-phenylalanine
• BDBM60928
• beta-(3,4-Dihydroxyphenyl)-alpha-alanine
• CTK1H2187
• ERK5-2K06
• HMS501G14
• HY-N0304R
• KBio1_000452
• KBio2_000934
• KBio2_003502
• KBio2_006070
• PARCOPA COMPONENT LEVODOPA
• Alanine, 3-(3,4-dihydroxyphenyl)-, (-)-
• CID6047
• L-.beta.-(3,4-Dihydroxyphenyl)alanine
• Levodopa [USAN:BAN:INN:JAN]
• LEVODOPUM [WHO-IP LATIN]
• MSK1487
• N04BA01
• Alanine,4-dihydroxyphenyl)-, L-
• CARBILEV COMPONENT LEVODOPA
• CHEBI:233994
• DOPASNAP COMPONENT LEVODOPA
• IPX203 COMPONENT LEVODOPA
• L-(3, 4-Dihydroxyphenyl)alanine
• NINDS_000452
• .beta.-(3,4-Dihydroxyphenyl)alanine
• 3-Ethoxy-4-fluorophenylboronicacid
• GLXC-07334
• HMS1568C15
• HMS1922J14
• HMS2090O08
• HMS2093N04
• HMS2095C15
• HMS2230B04
• HMS3261K10
• HMS3712C15
• LEVODOPA (REFERENCE GRADE)
• Levodopa [USAN:USP:INN:BAN:JAN]
• Pharmakon1600-02300205
• ZINC895199
• .beta.-(3,4-Dihydroxyphenyl)-L-alanine
• C9-H11-N-O4
• CID:6047
• HY-N0304
• IPX-203 COMPONENT LEVODOPA
• Levodopa;3,4-Dihydroxyphenylalanine
• b-(3,4-Dihydroxyphenyl)-L-alanine
• CAS-59-92-7
• Inbrija (levodopa inhalation powder)
• L-Dopa 99 % for biochemistry 5gm
• LEVODOPA COMPONENT OF PARCOPA
• LEVODOPA COMPONENT OF SINEMET
• Tox21_110338
• Tox21_500454
• (-)-3,4-Dihydroxy-L-phenylalanine
• 2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid
• ANW-33396
• BDBM50130192
• CCG-39571
• EBC-12565
• HB1925
• KM0355
• L-3-(3,4-dihydroxy-phenyl)alanine
• L-3-(3,4-dihydroxyphenyl)-Alanine
• LS-255
• NCGC00016270-04
• NSC759573
• PDSP1_001541
• PDSP2_001525
• s1726
• SBB017533
• 46627O600J
• Alanine, 3-(3,4-dihydroxyphenyl)-
• Alanine,4-dihydroxyphenyl)-, (-)-
• LEVODOPA COMPONENT OF CARBILEV
• AKOS010396267
• b-(3,4-Dihydroxyphenyl)-a-L-alanine
• L-(3,4-Dihydroxyphenyl)-.alpha.-alanine
• L-b-(3,4-Dihydroxyphenyl)-a-alanine
• L-DOPA (3,4-Dihydroxyphenylalanine)
• .beta.-(3, 4-Dihydroxyphenyl)alanine
• AC-8432
• ACN-038322
• AM82124
• AN-1108
• BAT-008090
• CS-1945
• DB01235
• FD15635
• J9.225H
• LP00454
• NSC-759573
• Ro-4-6316
• RTR-020755
• SDCCGMLS-0066924.P001
• SDCCGSBI-0050439.P004
• VA11170
• IDI1_000452
• V-1512
• NCGC00015384-01
• NCGC00016270-01
• NCGC00016270-06
• NCGC00016270-07
• NCGC00016270-09
• NCGC00016270-10
• NCGC00016270-22
• NCGC00093869-04
• NCGC00261139-01
• Y-224 ,a-
• 3,4-Dihydroxy-L-phenylalanine, 98% 5g
• AJ-24154
• AK187821
• AS-13287
• BC677906
• BP-12850
• H813
• SC-10704
• SID:53790373
• SMR000058312
• ST086623
• SY010977
• SBI-0050439.P003
• (--)-3-(3,4-Dihydroxyphenyl)-L-alanine
• AB0013279
• AB1009504
• L-(3, 4-Dihydroxyphenyl)-.alpha.-alanine
• TR-020755
• (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate
• A8460
• D0600
• D9628
• EU-0100454
• FT-0603250
• FT-0650636
• FT-0667771
• FT-0695064
• FT-0775213
• FT-0777729
• N1648
• NS00068395
• 2-Amino-3-(3,4-dihydroxyphenyl)propanoicacid
• EN300-52637
• 59L927
• Alanine, 3-(3, 4-dihydroxyphenyl)-, (-)-
• C00355
• D 9628
• D00059
• D70595
• J10404
• 13173-EP2269989A1
• 13173-EP2277876A1
• 13173-EP2277882A1
• 13173-EP2281559A1
• 13173-EP2281815A1
• 13173-EP2292614A1
• 13173-EP2295412A1
• 13173-EP2295413A1
• 13173-EP2295439A1
• 13173-EP2298731A1
• 13173-EP2301933A1
• 13173-EP2301934A1
• 13173-EP2305633A1
• 13173-EP2305640A2
• 13173-EP2308867A2
• 13173-EP2308870A2
• 13173-EP2311827A1
• 13173-EP2311837A1
• 13173-EP2314571A2
• 13173-EP2316470A2
• 13173-EP2316834A1
• 21660-EP2272832A1
• 21660-EP2275420A1
• 21660-EP2281559A1
• 21660-EP2301934A1
• 21660-EP2314571A2
• 21920-EP2295410A1
• 21920-EP2301939A1
• 21920-EP2314571A2
• 3,4-Dihydroxy-L-phenylalanine, >=98% (TLC)
• 3-(3,4-Dihydroxyphenyl-2,5,6-d3)-L-alanine
• AB00052418-06
• AB00052418-07
• AB00052418_08
• AB00052418_09
• DA
• A832543
• D007980
• F358380
• Q300989
• SR-01000075384
• (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoicacid
• (S)-2-Amino-3-(3,4-dihydroxyphenyl)propionic acid
• (S)-alpha-Amino-3,4-dihydroxybenzenepropanoic acid
• SR-01000075384-1
• SR-01000075384-4
• SR-01000075384-6
• SR-01000075384-7
• (--)-2Amino-3-(3,4-dihydroxyphenyl)propanoic Acid
• (2S)-2-azaniumyl-3-(3,4-dihydroxyphenyl)propanoate
• (2S)-3-(3,4-Dihydroxyphenyl)-2-aminopropanoic acid
• (S)-2-Amino-3-(3,4-dihydroxyphenyl) propanoic acid
• BRD-K34730807-001-15-0
• BRD-K34730807-001-16-8
• BRD-K34730807-001-17-6
• I01-10387
• Levodopa (optimized formulation, Parkinson's disease)
• LEVODOPA/CARBIDOPA/ENTACAPONE ORION COMPONENT LEVODOPA
• More effective levodopa (Parkinson's disease), Orion
• (S)-2-Amino-3-(3,4-dihydroxy-phenyl)-propionic acid
• F0347-4695
• Levodopa Working Standard (Secondary Reference Standard)
• Levodopa, 99%, a natural form of DOPA - 100G 100g
• Levodopa, British Pharmacopoeia (BP) Reference Standard
• Levodopa, European Pharmacopoeia (EP) Reference Standard
• Z756440064
• (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acidL-dopa
• 1E83F927-C221-46AA-B90A-81B33C5F3868
• 3,4-Dihydroxy-L-phenylalanine, Vetec(TM) reagent grade, 98%
• 587-45-1
• Levodopa (optimized formulation, Parkinson's disease), Orion
• Levodopa, United States Pharmacopeia (USP) Reference Standard
• L-3-(3,4-Dihydroxyphenyl)alanine（L-DOPA ）
• (2S)-2-amino-3-(2,3,6-trideuterio-4,5-dihydroxyphenyl)propanoic acid
• 3,4-Dihydroxy-L-phenylalanine, certified reference material, TraceCERT(R)
• 3-(3,4-Dihydroxyphenyl)-L-alanine; L-3-Hydroxytyrosine; L-DOPA; Levodopa
• 53587-29-4
• 63-84-3
• 65170-01-6
• DAH
• L-3
• Levodopa, Pharmaceutical Secondary Standard; Certified Reference Material
• 122769-74-8
• 1421-65-4
• 200-445-2
• 555-30-6
• 5796-17-8
• L-Methyldopa ; (2S)-2-Amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid; 3-(3,4-Dihydroxyphenyl)-?-methyl-L-alanine; 3-Hydroxy-a-methyl-L-tyrosine
• N/A